Pavlatos N, Kalra D
Biomedicines. 2024; 12(6).
PMID: 38927436
PMC: 11200468.
DOI: 10.3390/biomedicines12061229.
Tsimikas S
Arterioscler Thromb Vasc Biol. 2024; 44(7):1485-1490.
PMID: 38924439
PMC: 11210685.
DOI: 10.1161/ATVBAHA.124.319483.
Khan T, Bragazzi Cunha J, Raut C, Burroughs M, Goonewardena S, Smrcka A
bioRxiv. 2024; .
PMID: 38766193
PMC: 11100788.
DOI: 10.1101/2024.05.11.593568.
Waldron C, Zafar M, Ziganshin B, Weininger G, Grewal N, Elefteriades J
Int J Mol Sci. 2023; 24(21).
PMID: 37958625
PMC: 10650782.
DOI: 10.3390/ijms242115640.
Raitakari O, Kartiosuo N, Pahkala K, Hutri-Kahonen N, Bazzano L, Chen W
Circulation. 2022; 147(1):23-31.
PMID: 36440577
PMC: 9797445.
DOI: 10.1161/CIRCULATIONAHA.122.060667.
disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study.
Doerfler A, Park S, Assini J, Youssef A, Saxena L, Yaseen A
Mol Ther Methods Clin Dev. 2022; 27:337-351.
PMID: 36381302
PMC: 9630778.
DOI: 10.1016/j.omtm.2022.10.009.
Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.
Kostner K, Kostner G
Int J Mol Sci. 2022; 23(7).
PMID: 35408941
PMC: 8998850.
DOI: 10.3390/ijms23073584.
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Reyes-Soffer G, Ginsberg H, Berglund L, Duell P, Heffron S, Kamstrup P
Arterioscler Thromb Vasc Biol. 2021; 42(1):e48-e60.
PMID: 34647487
PMC: 9989949.
DOI: 10.1161/ATV.0000000000000147.
The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis.
Lin Y, Hidru T, Fan R, Gao J, Li H, Yang X
Front Cardiovasc Med. 2021; 8:732715.
PMID: 34497839
PMC: 8419518.
DOI: 10.3389/fcvm.2021.732715.
Lipoprotein (a): a historical appraisal.
Kostner K, Kostner G
J Lipid Res. 2016; 58(1):1-14.
PMID: 27821413
PMC: 5234731.
DOI: 10.1194/jlr.R071571.
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
Nordestgaard B, Langsted A
J Lipid Res. 2016; 57(11):1953-1975.
PMID: 27677946
PMC: 5087876.
DOI: 10.1194/jlr.R071233.
Lipoprotein (a): Coming of Age at Last.
Witztum J, Ginsberg H
J Lipid Res. 2016; 57(3):336-9.
PMID: 26839334
PMC: 4766984.
DOI: 10.1194/jlr.E066985.
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?.
Boffa M, Koschinsky M
J Lipid Res. 2015; 57(5):745-57.
PMID: 26647358
PMC: 4847635.
DOI: 10.1194/jlr.R060582.
Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.
Shiffman D, OMeara E, Bare L, Rowland C, Louie J, Arellano A
Arterioscler Thromb Vasc Biol. 2007; 28(1):173-9.
PMID: 17975119
PMC: 2636623.
DOI: 10.1161/ATVBAHA.107.153981.
Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice.
Teivainen P, Eliassen K, Rubin E, Djurovic S, Berg K
Lipids Health Dis. 2004; 3:8.
PMID: 15134578
PMC: 434526.
DOI: 10.1186/1476-511X-3-8.
Insulin sensitivity and Lp(alpha) concentrations in normoglycemic offspring of type 2 diabetic parents.
Psyrogiannis A, Habeos I, Kyriazopoulou V
Lipids Health Dis. 2003; 2:8.
PMID: 14613579
PMC: 272939.
DOI: 10.1186/1476-511X-2-8.
Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery.
Skinner J, Farrer M, Albers C, Piper K, Neil H, Adams P
Heart. 1997; 78(2):131-5.
PMID: 9326985
PMC: 484891.
DOI: 10.1136/hrt.78.2.131.
Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Farrer M, Game F, Albers C, Neil H, Winocour P, Laker M
BMJ. 1993; 307(6908):832-6.
PMID: 8401124
PMC: 1678874.
DOI: 10.1136/bmj.307.6908.832.
Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.
Feussner G, Wagner A, Ziegler R
Hum Genet. 1993; 92(2):122-6.
PMID: 8370576
DOI: 10.1007/BF00219678.
Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen F, Voldsgaard A, Gall M, Rossing P, Hommel E, Andersen P
Diabetologia. 1993; 36(5):438-44.
PMID: 8314449
DOI: 10.1007/BF00402281.
